Can-Fite BioPharma Ltd. (CANF) stock
CANFNYSEPharmaceutical PreparationsFiscal year ends December 31
$1.42−0.07 (-4.70%)
Close on Nov 13, 2026Market cap $1.86MP/E –Yield –
Can-Fite BioPharma total assets
Total assets on the balance sheet at the end of each period.
Can-Fite BioPharma's total assets was $8.06M at Jun 30, 2026. For fiscal 2025 it was $9.51M, up 4.3% from the year before. The highest annual figure on record is $20.25M in fiscal 2021.
Annual total assets
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $9.51M | +4.3% |
| FY2024 | Dec 31, 2024 | $9.12M | -8.7% |
| FY2023 | Dec 31, 2023 | $9.99M | +7.6% |
| FY2022 | Dec 31, 2022 | $9.28M | -54.2% |
| FY2021 | Dec 31, 2021 | $20.25M | +112.7% |
| FY2020 | Dec 31, 2020 | $9.52M | +16.5% |
| FY2019 | Dec 31, 2019 | $8.17M | +2.8% |
| FY2018 | Dec 31, 2018 | $7.95M | +4.4% |
| FY2017 | Dec 31, 2017 | $7.61M | -25.1% |
| FY2016 | Dec 31, 2016 | $10.17M | – |
Quarterly total assets
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $8.06M | +36.0% |
| Q4 FY2025 | Dec 31, 2025 | $9.51M | -4.8% |
| Q2 FY2025 | Jun 30, 2025 | $7.72M | -30.0% |
| Q4 FY2024 | Dec 31, 2024 | $9.12M | -1.8% |
| Q2 FY2024 | Jun 30, 2024 | $5.92M | -59.8% |
| Q4 FY2023 | Dec 31, 2023 | $9.99M | -50.7% |
| Q2 FY2023 | Jun 30, 2023 | $11.03M | +14.0% |
| Q4 FY2022 | Dec 31, 2022 | $9.28M | -2.5% |
| Q2 FY2022 | Jun 30, 2022 | $14.75M | +15.2% |
| Q4 FY2021 | Dec 31, 2021 | $20.25M | +147.8% |
| Q2 FY2021 | Jun 30, 2021 | $9.68M | -29.2% |
| Q4 FY2020 | Dec 31, 2020 | $9.52M | +19.8% |
| Q2 FY2020 | Jun 30, 2020 | $12.80M | +16.5% |
| Q4 FY2019 | Dec 31, 2019 | $8.17M | +7.4% |
| Q2 FY2019 | Jun 30, 2019 | $13.67M | +34.4% |
| Q4 FY2018 | Dec 31, 2018 | $7.95M | – |
| Q2 FY2018 | Jun 30, 2018 | $10.98M | – |
| Q4 FY2017 | Dec 31, 2017 | $7.61M | – |
| Q4 FY2016 | Dec 31, 2016 | $10.17M | – |
See a number that looks wrong?